For procurement managers and R&D scientists in the pharmaceutical industry, securing a consistent and high-quality supply of critical intermediates is paramount. One such compound, 1-[3-(Benzoyloxy)propyl]-2,3-dihydro-5-(2-nitropropyl)-1H-indole-7-carbonitrile, identified by CAS number 350797-56-7, plays a pivotal role in the synthesis of Silodosin, a widely used medication for benign prostatic hyperplasia (BPH). Understanding how to effectively source this advanced indole derivative can significantly impact production timelines and cost-effectiveness.

The global market for pharmaceutical intermediates is dynamic, and China has emerged as a key manufacturing hub. When looking to buy 1-[3-(Benzoyloxy)propyl]-2,3-dihydro-5-(2-nitropropyl)-1H-indole-7-carbonitrile, partnering with a reputable manufacturer or supplier based in China offers distinct advantages. These include competitive price points, economies of scale, and access to sophisticated manufacturing capabilities. However, diligence is key to ensure the purity and reliability of the product.

Key considerations for procurement include the purity specifications, consistency of batch-to-batch quality, and the robustness of the supply chain. A trusted supplier will readily provide comprehensive Certificates of Analysis (CoA) detailing the purity of the 350797-56-7 compound, along with information on its molecular formula (C22H23N3O4) and molecular weight (393.44). These details are crucial for R&D scientists and formulators to integrate the intermediate seamlessly into their synthesis pathways.

When searching for a manufacturer, look for those with established expertise in indole chemistry and a proven track record in producing pharmaceutical intermediates. Inquiring about lead times, minimum order quantities (MOQs), and shipping options (ocean, air, land) is also essential for effective inventory management. Utilizing terms like 'pharmaceutical intermediate supplier China' or 'buy Silodosin impurity 350797-56-7' can help refine your search on B2B platforms.

The importance of this specific compound as a precursor to Silodosin cannot be overstated. Therefore, ensuring a stable and dependable source for 1-[3-(Benzoyloxy)propyl]-2,3-dihydro-5-(2-nitropropyl)-1H-indole-7-carbonitrile is a strategic imperative for pharmaceutical companies. By focusing on quality, reliability, and competitive pricing, procurement managers can secure the necessary materials to meet the growing demand for Silodosin, ultimately benefiting patients worldwide.